Spectrum Pharmaceuticals, Inc. (SPPI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

0.7390

-0.0866

(-10.49%)

At close: 01:40PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Zacks
Spectrum Pharmaceuticals (SPPI) Reports Q4 Loss, Tops Revenue Estimates
Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 33.33% and 5.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates
  Zacks
- Fathom Holdings (FTHM) Reports Q4 Loss, Tops Revenue Estimates
  Zacks
Business Wire
Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
BOSTON, March 22, 2023--Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
Business Wire
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
BOSTON, March 17, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the fourth quarter and full year 2022 financial results and provide a corporate update on Wednesday, March 22, 2023, at 8:30 a.m. Eastern/5:30 a.m. Pacific.